CJR-X arrives January 1, 2028, moving the financial risk for hip, knee and ankle replacement episodes onto hospitals. Many of the decisions that shape those costs, though, happen well beyond the hospital’s walls.
To help operations leaders get ahead of it, this discussion brings together an orthopedic operations leader from Duke University School of Medicine, the executive director of physician group Signature Medical Group, and a value-based care and outcome-measurement director from Dell Medical School at the University of Texas at Austin.
Together they’ll map where episode costs hide, how to align hospital and physician priorities and gain-sharing and how reliable patient-reported outcome data can support both care improvement and CJR-X performance.
In this discussion, you’ll learn:
- Where episode-cost visibility breaks down, and how to strengthen care coordination
- Which lessons from earlier bundled payment models carry into CJR-X, and which assumptions need a second look
- How to align hospital and physician responsibilities, incentives and gain-sharing arrangements